If you made any changes in Pure these will be visible here soon.

Research Output 1983 2019

  • 4542 Citations
  • 32 h-Index
  • 95 Article
  • 3 Review article
Filter
Article
2019
1 Citation (Scopus)

Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survival

Spina, F., Radice, T., De Philippis, C., Soldarini, M., Di Chio, M. C., Dodero, A., Guidetti, A., Viviani, S. & Corradini, P., Jan 2 2019, In : Leukemia and Lymphoma. 60, 1, p. 101-109 9 p.

Research output: Contribution to journalArticle

Homologous Transplantation
Stem Cell Transplantation
Graft vs Host Disease
Hodgkin Disease
Recurrence
2018
36 Citations (Scopus)

Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mule, A., Picardi, M., Romano, A., Cantonetti, M., Nasa, G. L., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., Feb 10 2018, In : Journal of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Disease-Free Survival
Vincristine
Doxorubicin

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mulé, A., Picardi, M., Romano, A., Cantonetti, M., La Nasa, G., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., Feb 10 2018, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Disease-Free Survival
Vincristine
Doxorubicin

Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mule, A., Picardi, M., Romano, A., Cantonetti, M., Nasa, G. L., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., 2018, In : Journal of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Disease-Free Survival
Vincristine
Doxorubicin
Hodgkin Disease
Antibodies
Pharmaceutical Preparations
Chemotherapy
Refractory materials

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

Moskowitz, C. H., Walewski, J., Nademanee, A., Masszi, T., Agura, E., Holowiecki, J., Abidi, M. H., Chen, A. I., Stiff, P., Viviani, S., Bachanova, V., Sureda, A., McClendon, T., Lee, C., Lisano, J. & Sweetenham, J., Dec 20 2018, In : Blood. 132, 25, p. 2639-2642 4 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Disease-Free Survival
Recurrence
Placebos
Confidence Intervals

Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma

Tiacci, E., Ladewig, E., Schiavoni, G., Penson, A., Fortini, E., Pettirossi, V., Wang, Y., Rosseto, A., Venanzi, A., Vlasevska, S., Pacini, R., Piattoni, S., Tabarrini, A., Pucciarini, A., Bigerna, B., Santi, A., Gianni, A. M., Viviani, S., Cabras, A., Ascani, S. & 5 others, Crescenzi, B., Mecucci, C., Pasqualucci, L., Rabadan, R. & Falini, B., May 31 2018, In : Blood. 131, 22, p. 2454-2465 12 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Mutation
Genes
Neoplasms
Young Adult
2017
1 Citation (Scopus)
Hodgkin Disease
Serum
Therapeutics
Chemokine CCL17
Healthy Volunteers
10 Citations (Scopus)

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study

Zwarthoed, C., El-Galaly, T. C., Canepari, M., Ouvrier, M. J., Viotti, J., Ettaiche, M., Viviani, S., Rigacci, L., Trentin, L., Rusconi, C., Luminari, S., Cantonetti, M., Bolis, S., Borra, A., Darcourt, J., Salvi, F., Subocz, E., Tajer, J., Kulikowski, W., Malkowski, B. & 2 others, Zaucha, J. M. & Gallamini, A., Aug 2017, In : Journal of Nuclear Medicine. 58, 8, p. 1249-1254 6 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Positron-Emission Tomography
Bone Marrow
Fluorodeoxyglucose F18
Dacarbazine
8 Citations (Scopus)

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials

Eichenauer, D. A., Becker, I., Monsef, I., Chadwick, N., de Sanctis, V., Federico, M., Fortpied, C., Gianni, A. M., Henry-Amar, M., Hoskin, P., Johnson, P., Luminari, S., Bellei, M., Pulsoni, A., Sydes, M. R., Valagussa, P., Viviani, S., Engert, A. & Franklin, J., Oct 2017, In : Haematologica. 102, 10, p. 1748-1757 10 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Disease-Free Survival
Meta-Analysis
Randomized Controlled Trials
Drug Therapy
2 Citations (Scopus)

The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson?

Viviani, S., Tabanelli, V. & Pileri, S. A., Mar 1 2017, In : Tumori. 103, 2, p. 101-113 13 p.

Research output: Contribution to journalArticle

2016
10 Citations (Scopus)

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

Ramsey, S. D., Nademanee, A., Masszi, T., Holowiecki, J., Abidi, M., Chen, A., Stiff, P., Viviani, S., Sweetenham, J. W., Radford, J., Zhu, Y., Bonthapally, V., Thomas, E., Richhariya, A., Hunder, N. N., Walewski, J. & Moskowitz, C. H., 2016, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Hodgkin Disease
Quality of Life
Transplants
Arm
2015
23 Citations (Scopus)
Stem Cell Transplantation
Hodgkin Disease
Disease-Free Survival
Compassionate Use Trials
Survival
14 Citations (Scopus)

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory Hodgkin's lymphoma: Experience with 27 patients

Zinzani, P. L., Vitolo, U., Viviani, S., Corradini, P., Motta, G., Tani, M., Cascavilla, N., Hohaus, S., Merli, F., Argnani, L. & Broccoli, A., Jul 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 7, p. 404-408 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Safety
Retrospective Studies
Bendamustine Hydrochloride
cAC10-vcMMAE
2014
20 Citations (Scopus)

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: A retrospective study of the Fondazione Italiana Linfomi

Anastasia, A., Carlo-Stella, C., Corradini, P., Salvi, F., Rusconi, C., Pulsoni, A., Hohaus, S., Pregno, P., Viviani, S., Brusamolino, E., Luminari, S., Giordano, L. & Santoro, A., 2014, In : British Journal of Haematology. 166, 1, p. 140-142 3 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)
Therapeutics
Hodgkin Disease
perifosine
sorafenib
Arthralgia
8 Citations (Scopus)

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis

Magni, M., Nicola, M. D., Patti, C., Scimè, R., Mulè, A., Rambaldi, A., Intermesoli, T., Viero, P., Tarella, C., Gueli, A., Bergui, L., Trentin, L., Barzan, A., Benedetti, F., Ambrosetti, A., Di Raimondo, F., Chiarenza, A., Parvis, G., Billio, A., Attolico, I. & 9 others, Olivieri, A., Montanari, M., Carlo-Stella, C., Matteucci, P., Devizzi, L., Guidetti, A., Viviani, S., Valagussa, P. & Gianni, A. M., 2014, In : Bone Marrow Transplantation. 49, 4, p. 485-491 7 p.

Research output: Contribution to journalArticle

Stem Cells
Transplants
Drug Therapy
Arm
B-Lymphocytes
7 Citations (Scopus)
Chemokine CCL17
Pets
Stem Cell Transplantation
Hodgkin Disease
Positron-Emission Tomography
132 Citations (Scopus)

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

Gallamini, A., Barrington, S. F., Biggi, A., Chauvie, S., Kostakoglu, L., Gregianin, M., Meignan, M., Mikhaeel, G. N., Loft, A., Zaucha, J. M., Seymour, J. F., Hofman, M. S., Rigacci, L., Pulsoni, A., Coleman, M., Dann, E. J., Trentin, L., Casasnovas, O., Rusconi, C., Brice, P. & 5 others, Bolis, S., Viviani, S., Salvi, F., Luminari, S. & Hutchings, M., Jun 1 2014, In : Haematologica. 99, 6, p. 1107-1113 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Positron-Emission Tomography
Dacarbazine
Vinblastine
Bleomycin
2013
58 Citations (Scopus)

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: The Italian experience and results of its use in daily clinical practice outside clinical trials

Zinzani, P. L., Viviani, S., Anastasia, A., Vitolo, U., Luminari, S., Zaja, F., Corradini, P., Spina, M., Brusamolino, E., Gianni, A. M., Santoro, A., Botto, B., Derenzini, E., Pellegrini, C. & Argnani, L., Aug 1 2013, In : Haematologica. 98, 8, p. 1232-1236 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Clinical Trials
Disease-Free Survival
Therapeutics
Survival Rate
2011
251 Citations (Scopus)

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned

Viviani, S., Zinzani, P. L., Rambaldi, A., Brusamolino, E., Levis, A., Bonfante, V., Vitolo, U., Pulsoni, A., Liberati, A. M., Specchia, G., Valagussa, P., Rossi, A., Zaja, F., Pogliani, E. M., Pregno, P., Gotti, M., Gallamini, A., Scalabrini, D. R., Bonadonna, G. & Gianni, A. M., Jul 21 2011, In : New England Journal of Medicine. 365, 3, p. 203-212 10 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Bleomycin
Doxorubicin
Therapeutics
Procarbazine
111 Citations (Scopus)

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

Gallamini, A., Patti, C., Viviani, S., Rossi, A., Fiore, F., Di Raimondo, F., Cantonetti, M., Stelitano, C., Feldman, T., Gavarotti, P., Sorasio, R., Mulè, A., Leone, M., Rambaldi, A., Biggi, A., Barrington, S., Fallanca, F., Ficola, U., Chauvie, S. & Gianni, A. M., Mar 2011, In : British Journal of Haematology. 152, 5, p. 551-560 10 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Survival
Positron-Emission Tomography
Nuclear Medicine

The authors reply

Viviani, S., Valagussa, P. & Gianni, A. M., Oct 20 2011, In : New England Journal of Medicine. 365, 16, p. 1546 1 p.

Research output: Contribution to journalArticle

2010
117 Citations (Scopus)

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: A retrospective study based on the time of HLA typing and donor availability

Sarina, B., Castagna, L., Farina, L., Patriarca, F., Benedetti, F., Carella, A. M., Falda, M., Guidi, S., Ciceri, F., Bonini, A., Ferrari, S., Malagola, M., Morello, E., Milone, G., Bruno, B., Mordini, N., Viviani, S., Levis, A., Giordano, L., Santoro, A. & 1 others, Corradini, P., May 6 2010, In : Blood. 115, 18, p. 3671-3677 7 p.

Research output: Contribution to journalArticle

Salvaging
Histocompatibility Testing
Autologous Transplantation
Homologous Transplantation
Hodgkin Disease
9 Citations (Scopus)

Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease

Busia, A., Laffranchi, A., Viviani, S., Bonfante, V. & Villani, F., Oct 2010, In : Anticancer Research. 30, 10, p. 4381-4387 7 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Vincristine
Prednisone
Hodgkin Disease
Epirubicin
27 Citations (Scopus)
Salvage Therapy
Hodgkin Disease
Bone Marrow
Transplants
Drug Therapy
1 Citation (Scopus)

Radioimmunotherapy and secondary leukemia: A case report

Magni, M., Di Nicola, M., Testi, A., Cabras, A., Devizzi, L., Guidetti, A., Matteucci, P., Viviani, S., Bonfante, V., Carniti, C., Ricca, I., Carbone, A., Carlo-Stella, C. & Gianni, A. M., Jan 2010, In : Leukemia Research. 34, 1

Research output: Contribution to journalArticle

Radioimmunotherapy
Chromosomes, Human, Pair 16
Cytogenetics
Leukemia
Lymphoma, Large B-Cell, Diffuse
2009
12 Citations (Scopus)

Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease

Villani, F., Busia, A., Villani, M., Laffranchi, A., Viviani, S. & Bonfante, V., Feb 2009, In : Anticancer Research. 29, 2, p. 777-783 7 p.

Research output: Contribution to journalArticle

Radio
Hodgkin Disease
Exercise
Drug Therapy
Lung
2008
16 Citations (Scopus)

Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease

Villani, F., Busia, A., Villani, M., Vismara, C., Viviani, S. & Bonfante, V., Nov 2008, In : Tumori. 94, 6, p. 803-808 6 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiotherapy
Cytokines
Lung
Serum
2007
605 Citations (Scopus)

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: A report from a joint Italian-Danish study

Gallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., Biggi, A., Vitolo, U., Stelitano, C., Sancetta, R., Trentin, L., Luminari, S., Iannitto, E., Viviani, S., Pierri, I. & Levis, A., Aug 20 2007, In : Journal of Clinical Oncology. 25, 24, p. 3746-3752 7 p.

Research output: Contribution to journalArticle

Fluorodeoxyglucose F18
Hodgkin Disease
Positron-Emission Tomography
Therapeutics
Dacarbazine
2006
31 Citations (Scopus)

Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis

Visco, C., Nadali, G., Vassilakopoulos, T. P., Bonfante, V., Viviani, S., Gianni, A. M., Federico, M., Luminari, S., Peethambaram, P., Witzig, T. E., Pangalis, G., Cabanillas, F., Medeiros, L. J., Sarris, A. H. & Pizzolo, G., Nov 2006, In : European Journal of Haematology. 77, 5, p. 387-394 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Survival
Serum
Dacarbazine
Vinblastine
2005
43 Citations (Scopus)

Survival in Hodgkin's disease patients - Report of 25 years of experience at the Milan Cancer Institute

Bonadonna, G., Viviani, S., Bonfante, V., Gianni, A. M. & Valagussa, P., May 2005, In : European Journal of Cancer. 41, 7, p. 998-1006 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Dacarbazine
Vinblastine
Bleomycin
Doxorubicin
2004
256 Citations (Scopus)

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results

Bonadonna, G., Bonfante, V., Viviani, S., Di Russo, A., Villani, F. & Valagussa, P., 2004, In : Journal of Clinical Oncology. 22, 14, p. 2835-2841 7 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiotherapy
Spleen
Dacarbazine
Second Primary Neoplasms
29 Citations (Scopus)

Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy

Visco, C., Vassilakopoulos, T. P., Kliche, K. O., Nadali, G., Viviani, S., Bonfante, V., Medeiros, L. J., Notti, P., Rassidakis, G. Z., Peethambaram, P., Wilder, R., Witzig, T., Gianni, M., Bonadonna, G., Pizzolo, G., Pangalis, G. A., Cabanillas, F. & Sarris, A. H., Oct 2004, In : Leukemia and Lymphoma. 45, 10, p. 2085-2092 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Interleukin-10
Disease-Free Survival
Radiotherapy
Serum
2003
5 Citations (Scopus)

Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin's disease

Villani, F., Catania, A. F., Laffranchi, A., Maffioli, L., Viviani, S. & Bonfante, V., 2003, In : Cancer Investigation. 21, 2, p. 185-192 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Lung
Stroke Volume
Electrocardiography
54 Citations (Scopus)

Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: Associations with presenting features, serum interleukin 10 levels, and clinical outcome

Herling, M., Rassidakis, G. Z., Medeiros, L. J., Vassilakopoulos, T. P., Kliche, K. O., Nadali, G., Viviani, S., Bonfante, V., Giardini, R., Chilosi, M., Kittas, C., Gianni, A. M., Bonadonna, G., Pizzolo, G., Pangalis, G. A., Cabanillas, F. & Sarris, A. H., Jun 1 2003, In : Clinical Cancer Research. 9, 6, p. 2114-2120 7 p.

Research output: Contribution to journalArticle

Reed-Sternberg Cells
Hodgkin Disease
Interleukin-10
Membrane Proteins
Serum
2002
26 Citations (Scopus)

BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: Correlation with clinical outcome

Rassidakis, G. Z., Medeiros, L. J., McDonnell, T. J., Viviani, S., Bonfante, V., Nadali, G., Vassilakopoulos, T. P., Giardini, R., Chilosi, M., Kittas, C., Gianni, A. M., Bonadonna, G., Pizzolo, G., Pangalis, G. A., Cabanillas, F. & Sarris, A. H., 2002, In : Clinical Cancer Research. 8, 2, p. 488-493 6 p.

Research output: Contribution to journalArticle

Reed-Sternberg Cells
Hodgkin Disease
Vinblastine
Vincristine
Prednisone
86 Citations (Scopus)

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

Rassidakis, G. Z., Medeiros, L. J., Vassilakopoulos, T. P., Viviani, S., Bonfante, V., Nadali, G., Herling, M., Angelopoulou, M. K., Giardini, R., Chilosi, M., Kittas, C., McDonnell, T. J., Bonadonna, G., Gianni, A. M., Pizzolo, G., Pangalis, G. A., Cabanillas, F. & Sarris, A. H., Dec 1 2002, In : Blood. 100, 12, p. 3935-3941 7 p.

Research output: Contribution to journalArticle

Reed-Sternberg Cells
Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
82 Citations (Scopus)

CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: Associations with presenting features and clinical outcome

Rassidakis, G. Z., Medeiros, L. J., Viviani, S., Bonfante, V., Nadali, G. P., Vassilakopoulos, T. P., Mesina, O., Herling, M., Angelopoulou, M. K., Giardini, R., Chilosi, M., Kittas, C., McLaughlin, P., Rodriguez, M. A., Romaguera, J., Bonadonna, G., Gianni, A. M., Pizzolo, G., Pangalis, G. A., Cabanillas, F. & 1 others, Sarris, A. H., Mar 1 2002, In : Journal of Clinical Oncology. 20, 5, p. 1278-1287 10 p.

Research output: Contribution to journalArticle

Reed-Sternberg Cells
Hodgkin Disease
Vinblastine
Survival
Radiotherapy
10 Citations (Scopus)

Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease

Villani, F., Viola, G., Vismara, C., Laffranchi, A., Di Russo, A., Viviani, S. & Bonfante, V., 2002, In : Anticancer Research. 22, 4, p. 2403-2408 6 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiotherapy
Cytokines
Drug Therapy
Lung
2001
9 Citations (Scopus)

Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: Results with ALK-11 antibody in 327 untreated patients

Herling, M., Rassidakis, G. Z., Viviani, S., Bonfante, V., Giardini, R., Gianni, M., Morris, S. W., Cabanillas, F., Medeiros, L. J. & Sarris, A. H., 2001, In : Leukemia and Lymphoma. 42, 5, p. 969-979 11 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Antibodies
anaplastic lymphoma kinase
Anaplastic Large-Cell Lymphoma
Null Lymphocytes
23 Citations (Scopus)

High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease

Bonfante, V., Viviani, S., Devizzi, L., Di Russo, A., Di Nicola, M., Magni, M., Matteucci, P., Grisanti, S., Valagussa, P., Bonadonna, G. & Gianni, A. M., 2001, In : European Journal of Haematology, Supplement. 61, 64, p. 51-55 5 p.

Research output: Contribution to journalArticle

Salvage Therapy
Ifosfamide
Hodgkin Disease
Radiotherapy
Mesna
2000
41 Citations (Scopus)

Elevated pretreatment serum levels of IL-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience

Viviani, S., Notti, P., Bonfante, V., Verderio, P., Valagussa, P. & Bonadonna, G., 2000, In : Medical Oncology. 17, 1, p. 59-63 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Interleukin-10
Serum
Neoplasms
Immunosuppression
190 Citations (Scopus)

Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study

Santoro, A., Bredenfeld, H., Devizzi, L., Tesch, H., Bonfante, V., Viviani, S., Fiedler, F., Soto Parra, H., Benoehr, C., Pacini, M., Bonadonna, G. & Diehl, V., Jul 2000, In : Journal of Clinical Oncology. 18, 13, p. 2615-2619 5 p.

Research output: Contribution to journalArticle

gemcitabine
Hodgkin Disease
Therapeutics
Drug Therapy
21 Citations (Scopus)

Late pulmonary effects in favorable stage I and IIA Hodgkin's disease treated with radiotherapy alone

Villani, F., Viviani, S., Bonfante, V., De Maria, P., Soncini, F. & Laffranchi, A., Feb 2000, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 23, 1, p. 18-21 4 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiotherapy
Lung
Total Lung Capacity
Transfer Factor
1999
8 Citations (Scopus)
Disease control
Immunotherapy
Interleukin-2
Lymphoma
Blood
38 Citations (Scopus)

Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease

Viviani, S., Bonfante, V., Santoro, A., Zanini, M., Devizzi, L., Di Russo, A., Soncini, F., Villani, F., Ragni, G., Valagussa, P. & Bonadonna, G., Sep 1999, In : The cancer journal from Scientific American. 5, 5, p. 275-282 8 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Radiotherapy
Drug Therapy
Intercellular Signaling Peptides and Proteins
Epirubicin
4 Citations (Scopus)

Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease

Villani, F., Dell'Oca, I., De Maria, P., Viola, G., Russo, A. D., Viviani, S. & Bonfante, V., 1999, In : Anticancer Research. 19, 5 C, p. 4475-4479 5 p.

Research output: Contribution to journalArticle

Mediastinal Diseases
Hodgkin Disease
Fibronectins
Interleukin-6
Radiotherapy
1998
36 Citations (Scopus)

Ifosfamide and vinorelbine: An active regimen for patients with relapsed or refractory Hodgkin's disease

Bonfante, V., Viviani, S., Santoro, A., Devizzi, L., Di Russo, A., Zanini, M., Soncini, F., Parra, H. S., Valagussa, P. & Bonadonna, G., 1998, In : British Journal of Haematology. 103, 2, p. 533-535 3 p.

Research output: Contribution to journalArticle

Ifosfamide
Hodgkin Disease
Mesna
Poisons
Granulocyte Colony-Stimulating Factor